Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Novartis AG プロフィール



企業コードNVS

会社名Novartis AG

上場日May 07, 2001

最高経営責任者「CEO」Narasimhan (Vasant)

従業員数75883

証券種類Depository Receipt

決算期末May 07

本社所在地Lichtstrasse 35

都市BASEL

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国Switzerland

郵便番号4056

電話番号41613241111

ウェブサイトhttps://www.novartis.com/

企業コードNVS

上場日May 07, 2001

最高経営責任者「CEO」Narasimhan (Vasant)

Novartis AGの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Charlotte Pamer-Wieser, Ph.D.

Corporate Secretary

Dr. Nancy C. Andrews, M.D., Ph.D.

Non-Executive Independent Director

Mr. Ton Buechner

Non-Executive Independent Director

Ms. Elizabeth (Liz) Doherty

Non-Executive Independent Director

Dr. Vasant (Vas) Narasimhan, M.D.

Chief Executive Officer, Member of the Executive Committee

Mr. Frans van Houten

Non-Executive Independent Director

Dr. Steffen Lang, Ph.D.

President - Operations, Member of the Executive Committee

Mr. Patrice Bula

Non-Executive Lead Independent Director

Ms. Bridgette P. Heller

Non-Executive Independent Director

Dr. Simon E. Moroney

Independent Non-Executive Vice Chairman of the Board

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Charlotte Pamer-Wieser, Ph.D.

Corporate Secretary

Dr. Nancy C. Andrews, M.D., Ph.D.

Non-Executive Independent Director

Mr. Ton Buechner

Non-Executive Independent Director

Ms. Elizabeth (Liz) Doherty

Non-Executive Independent Director

Dr. Vasant (Vas) Narasimhan, M.D.

Chief Executive Officer, Member of the Executive Committee

Mr. Frans van Houten

Non-Executive Independent Director

よくある質問

Novartis AGの上位5名の株主は誰ですか？



Novartis AGの上位5名の株主は以下のとおりです。Ms. Charlotte Pamer-Wieser, Ph.D.

Novartis AG（NVS）の株式を保有している機関の数はいくつですか？



2026Q1時点で、Novartis AGの株式を保有している機関は2164社あり、保有株式の総市場価値は約143.01Mで、全体の7.49%を占めています。2025Q4と比較して、機関の持ち株は-1630148.00増加しています。

Novartis AGの最大の収益源は何ですか？



2026Q1において、Rest of portfolio部門がNovartis AGにとって最大の収益を生み出しており、その金額は10.02Bで、全収益の18.37%を占めています。